Anti-tumour necrosis factor α therapy modulates ghrelin in patients with severe rheumatoid arthritis. Issue 11 (14th October 2008) - Gonzalez-Gay, M A; Garcia-Unzueta, M T; Berja, A; Vazquez-Rodriguez, T R; Gonzalez-Juanatey, C; de Matias, J M; Martin, J; Dessein, P H; Llorca, J